FINANCIAL STATEMENTS 163 26 lEASES Total rentals under operating leases charged to the income statement were as follows: 2008 2007 2006 $m $m $m 206 210 197 The future minimum lease payments under operating leases that have initial or remaining terms in excess of one year at 31 December 2008 were as follows: 2008 2007 2006 $m $m $m Obligations under leases comprise No later than one year 101 103 108 Rentals due after more than one year: Later than five years 145 184 161 Later than one year and not later than five years 212 195 182 357 379 343 458 482 451 27 STATuToRy ANd oThER INFoRmATIoN 2008 2007 2006 $m $m $m Fees payable to KPMG Audit Plc and its associates: Group audit fee 3.2 3.6 3.1 Fees payable to KPMG Audit Plc and its associates for other services: The audit of subsidiaries pursuant to legislation 7.1 6.1 5.4 Other services pursuant to legislation 3.3 3.6 4.1 Taxation 0.9 1.1 1.2 All other services 1.7 0.7 1.0 Fees payable to KPMG Audit Plc in respect of the Groups pension schemes: The audit of subsidiaries pension schemes 0.6 0.6 0.5 16.8 15.7 15.3 Other services pursuant to legislation includes fees of $2.5m 2007: $2.7m: 2006: $3.2m in respect of section 404 of the Sarbanes-Oxley Act.
Taxation services consist of tax compliance services and tax advice.
RElATEd pARTy TRANSACTIoNS The Group had no material related party transactions which might reasonably be expected to influence decisions made by the users of these Financial Statements.
kEy mANAgEmENT pERSoNNEl CompENSATIoN Key management personnel are defined for the purpose of disclosure under IAS 24 Related Party Disclosures as the Board of Directors, the Senior Executive Team and the Company Secretary.
2008 2007 2006 $000 $000 $000 Short-term employee benefits 21,973 31,525 21,321 Post-employment benefits 2,290 2,072 3,191 Share-based payments 13,210 11,515 8,417 37,473 45,112 32,929 Short-term employee benefits in 2007 include one-off employee costs of $11m in relation to the acquisition of MedImmune.
Total remuneration is included within employee costs Note 24.
SubSEquENT EvENTS There were no material subsequent events.
ASTRAZENECA ANNuAl REpoRT ANd FoRm 20-F INFoRmATIoN 2008
